Can I read Evidence for an Age and Gender Bias in the Secondary Prevention of Ischaemic Heart Disease in Primary Care on EtoBox?

Evidence for an Age and Gender Bias in the Secondary Prevention of Ischaemic Heart Disease in Primary Care by David Williams; Kathleen Bennett; John Feely is a Medicine article available to read on EtoBox.

What is Evidence for an Age and Gender Bias in the Secondary Prevention of Ischaemic Heart Disease in Primary Care about?

**Aims** To determine if a gender or age bias exists in the prescription of important secondary preventive therapies for ischaemic heart disease in primary care. **Methods** We identified 15 590 patients with ischaemic heart disease on the basis that they received a prescription for nitrate therapy over a 1‐year period (September 1999 to August 2000) from the Eastern Region of the General Medical Services scheme in Ireland (population of 334 031), which provides free health service to those eligible patients in primary care. Odds ratios (OR) for the prescription of aspirin, β‐blockers, statins, calcium channel antagonists and ACE inhibitors in women and in those aged> 65 years were determined. **Results** Female patients were less likely to receive a prescription for a β‐blocker [OR = 0.84, 95% confidence interval (CI) = 0.79, 0.89, __P__ < 0.001], aspirin (OR = 0.72, 95% CI = 0.67, 0.78, __P__ < 0.001), and ACE inhibitors (OR = 0.83, 95% CI = 0.78, 0.89, __P__ < 0.001) compared with their male counterparts. However, women were more likely to receive anxiolytic benzodiazepines (OR = 1.71, 95% CI = 1.59, 1.85, __P__ 65 years) were less likely to receive aspirin (OR = 0.92, 95% CI

Who reads Evidence for an Age and Gender Bias in the Secondary Prevention of Ischaemic Heart Disease in Primary Care?

Author

David Williams; Kathleen Bennett; John Feely

Publisher

John Wiley and Sons; Wiley (Blackwell Publishing); Blackwell Publishing Inc.; Wiley; Research Square (ISSN 0306-5251)

Published

2003

Language

EN

Field

Medicine (Health Sciences)